专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080015214A1 3-PIPERIDIN-4-YL-INDOLE ORL-1 RECEPTOR MODULATORS 审中-公开
标题翻译： 3-PIPERIDIN-4-YL-INDOLE ORL-1受体调节剂
公开(公告)号：US20080015214A1
公开(公告)日：2008-01-17
申请号：US11550421
申请日：2006-10-18
申请人： Gilles Bignan , Kathleen Battista , Peter Connolly , Jessica Liu , Steven Middleton , Michael Orsini , Allen Reitz
发明人： Gilles Bignan , Kathleen Battista , Peter Connolly , Jessica Liu , Steven Middleton , Michael Orsini , Allen Reitz
IPC分类号： A61K31/454 , A61K31/437 , A61K31/4545 , A61P1/00 , A61P25/00 , A61P9/00 , C07D401/02 , C07D401/14 , C07D471/02
CPC分类号： C07D401/04 , C07D405/14 , C07D471/04
摘要： The present invention is directed to novel 3-piperidin-4-yl-indole derivatives of formula (I) and forms thereof, wherein X, R1, R2, R3, R4 and R5 are as herein defined, pharmaceutical compositions thereof and use as ORL-1 receptor modulators for treating, preventing or ameliorating ORL-1 receptor mediated disorders and conditions.
摘要翻译：本发明涉及新的式（I）的3-哌啶-4-基 - 吲哚衍生物及其形式，其中X，R 1，R 2，R R 4，R 4和R 5如本文所定义，其药物组合物用作ORL-1受体调节剂，用于治疗，预防或改善 ORL-1受体介导的病症和病症。

2. 发明申请

US20070270425A1 SUBSTITUTED PYRIMIDINYL OXIME KINASE INHIBITORS 有权
标题翻译：取代的吡咯烷酮氧化酶抑制剂
公开(公告)号：US20070270425A1
公开(公告)日：2007-11-22
申请号：US11609450
申请日：2006-12-12
申请人： Guozhang Xu , Lily Lee , Terry Hughes , Steven Wetter , Peter Connolly , Marta Abad , Stuart Emanuel , Prabha Karnachi , Steven Middleton
发明人： Guozhang Xu , Lily Lee , Terry Hughes , Steven Wetter , Peter Connolly , Marta Abad , Stuart Emanuel , Prabha Karnachi , Steven Middleton
IPC分类号： A61K31/5377 , A61P43/00 , C07D239/48 , C07D413/02
CPC分类号： C07D239/48 , C07D401/12 , C07D403/12 , C07D407/12 , C07D413/04 , C07D417/12
摘要： The present invention is directed to substituted pyrimidine compounds of formula (I): and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
摘要翻译：本发明涉及式（I）的取代嘧啶化合物及其形式，其合成和用途，用于治疗，预防或改善慢性或急性蛋白激酶介导的疾病，病症或病症。

3. 发明申请

US20060223825A1 Piperazinyl substituted cyclohexane-1,4-diamines 有权
标题翻译：哌嗪基取代的环己烷-1,4-二胺
公开(公告)号：US20060223825A1
公开(公告)日：2006-10-05
申请号：US11376432
申请日：2006-03-15
申请人： George Chiu , Shengjian Li , Peter Connolly , Virginia Pulito , Jingchun Liu , Steven Middleton
发明人： George Chiu , Shengjian Li , Peter Connolly , Virginia Pulito , Jingchun Liu , Steven Middleton
IPC分类号： A61K31/496 , C07D403/04
CPC分类号： C07D213/74
摘要： The present invention relates to piperazine substituted cyclohexane- 1,4-diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as α1a/α1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.
摘要翻译：本发明涉及式（I）的哌嗪取代的环己烷-1,4-二胺化合物及其药学上可接受的形式，作为α1a1/α1D1肾上腺素受体调节剂治疗良性前列腺肥大和下尿路症状。本发明还涉及包含所述新化合物的药物组合物，制备这些新化合物的新方法和作为药物的新用途以及治疗方法。

4. 发明申请

US20060217419A1 Piperidinyl substituted cyclohexane-1,4-diamines 有权
标题翻译：哌啶基取代的环己烷-1,4-二胺
公开(公告)号：US20060217419A1
公开(公告)日：2006-09-28
申请号：US11376348
申请日：2006-03-15
申请人： George Chiu , Shengjian Li , Peter Connolly , Virginia Pulito , Jingchun Liu , Steven Middleton
发明人： George Chiu , Shengjian Li , Peter Connolly , Virginia Pulito , Jingchun Liu , Steven Middleton
IPC分类号： A61K31/454 , A61K31/445 , C07D401/02 , C07D211/26
CPC分类号： C07D211/14 , C07D211/22 , C07D405/12
摘要： The present invention relates to piperidine substituted cyclohexane-1,4-diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as α1a/α1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as method of treatments.
摘要翻译：本发明涉及式（I）的哌啶取代的环己烷-1,4-二胺化合物及其药学上可接受的形式，作为α1a1/α1d1肾上腺素受体调节剂治疗良性前列腺肥大和下尿路症状。本发明还涉及包含所述新化合物的药物组合物，制备这些新化合物的新方法和作为药物的新用途以及治疗方法。

5. 发明申请

US20060183900A1 Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders 有权
标题翻译：用于治疗激酶障碍的嘧啶基取代的稠合吡咯基化合物
公开(公告)号：US20060183900A1
公开(公告)日：2006-08-17
申请号：US11260986
申请日：2005-10-28
申请人： Shenlin Huang , Ronghui Lin , Peter Connolly , Stuart Emanuel , Steven Middleton
发明人： Shenlin Huang , Ronghui Lin , Peter Connolly , Stuart Emanuel , Steven Middleton
IPC分类号： A61K31/506 , C07D471/02
CPC分类号： C07D471/04
摘要： The present invention provides pyrimidinyl substituted fused-pyrrolyl compounds of Formula (I) and pharmaceutical compositions comprising the compounds and methods of synthesis and use thereof. The compounds are kinase inhibitors useful in treating or ameliorating a kinase mediated, angiogenesis-mediated or hyperproliferative disorder. The invention thus also provides a therapeutic or prophylactic method of use for the compounds and/or pharmaceutical compositions to treat such disorders.
摘要翻译：本发明提供式（I）的嘧啶基取代的稠合吡咯基化合物和包含该化合物的药物组合物及其合成和使用方法。该化合物是可用于治疗或改善激酶介导的血管生成介导的或过度增殖性疾病的激酶抑制剂。因此，本发明还提供了用于治疗这些疾病的化合物和/或药物组合物的治疗或预防方法。

6. 发明申请

US20060173015A1 Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms 审中-公开
标题翻译：环己基二胺作为选择性α1a / 1d肾上腺素受体拮抗剂治疗良性前列腺肥大和下尿路症状
公开(公告)号：US20060173015A1
公开(公告)日：2006-08-03
申请号：US11262551
申请日：2005-10-28
申请人： George Chiu , Shengjian Li , Peter Connolly , Virginia Pulito , Jessica Liu , Steven Middleton
发明人： George Chiu , Shengjian Li , Peter Connolly , Virginia Pulito , Jessica Liu , Steven Middleton
IPC分类号： A61K31/495 , A61K31/496 , C07D403/02 , C07D241/04
CPC分类号： C07D213/71 , C07D295/116
摘要： The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable form thereof, as dual selective α1a/α1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as method of treatments.
摘要翻译：本发明涉及用于治疗良性前列腺肥大的双重选择性α1A/α1D1肾上腺素受体拮抗剂的式（I）化合物或其药学上可接受的形式，下尿路症状。本发明还涉及包含所述新化合物的药物组合物，制备这些新化合物的新方法和作为药物的新用途以及治疗方法。

7. 发明申请

US20060058341A1 Thiazolopyridine kinase inhibitors 有权
标题翻译：噻唑并吡啶激酶抑制剂
公开(公告)号：US20060058341A1
公开(公告)日：2006-03-16
申请号：US11226961
申请日：2005-09-15
申请人： Peter Connolly , Sigmond Johnson , Niranjan Pandey , Steven Middleton
发明人： Peter Connolly , Sigmond Johnson , Niranjan Pandey , Steven Middleton
IPC分类号： A61K31/4745 , C07D498/02
CPC分类号： C07D497/04 , C07D513/04
摘要： The present invention is directed to novel thiazolopyridines, pharmaceutical compositions thereof, and the use thereof as inhibitors of ATP-protein kinase interactions. The thiazolopyridine compounds have the following Formula (I):
摘要翻译：本发明涉及新型噻唑并吡啶类，其药物组合物及其作为ATP-蛋白激酶相互作用抑制剂的用途。噻唑并吡啶化合物具有下式（I）：

8. 发明申请

US20120072233A1 MEDICAL HEALTH INFORMATION SYSTEM FOR HEALTH ASSESSMENT, WEIGHT MANAGEMENT AND MEAL PLANNING 审中-公开
公开(公告)号：US20120072233A1
公开(公告)日：2012-03-22
申请号：US13237648
申请日：2011-09-20
申请人： Alaina B. Hanlon , Peter Connolly , Steven K. Grinspoon
发明人： Alaina B. Hanlon , Peter Connolly , Steven K. Grinspoon
IPC分类号： G06Q50/24
CPC分类号： G06Q30/0271 , G06F19/3475 , G06Q50/22 , G16H50/30
摘要： A system and method provide nutrition assessments and tools for enabling users to achieve health-related goals based on specific health needs. The tools can include a nutrition assessment tool, a weight solution tool, a meal planning tool, and a meal tracking tool. The method includes receiving patient phenotype data. The phenotype data can include, but is not limited to, biometric data specific to the patient, medical claims data specific to the patient, organizational data specific to an organization to which the patient belongs, and behavioral data including dietary habits and nutritional history. One or more algorithms are executed on at least one processor of a computing apparatus to provide analyses of patient data in order. The results are output to a user in various web pages customized to provide features to the user.

9. 发明申请

US20090006235A1 PROCESSING CONTINGENT PAYMENTS 审中-公开
标题翻译：处理或不等的付款
公开(公告)号：US20090006235A1
公开(公告)日：2009-01-01
申请号：US12123928
申请日：2008-05-20
申请人： John Peter Connolly
发明人： John Peter Connolly
IPC分类号： G06Q20/00 , G06Q50/00
CPC分类号： G06Q20/10 , G06Q40/00
摘要： Methods and apparatus, including computer program products, implementing and using techniques for granting authorization to conduct a monetary transfer. A proposal is created. The proposal specifies one or more named third parties, one or more specified actions, and a time frame in which the one or more specified actions is to be completed. The proposal is distributed to the one or more named third parties. Each of the one or more named third parties completes the specified actions within the time frame specified in the proposal. Authorization to process the monetary transfer is given in response to the one or more specified actions being completed by the one or more named third parties.
摘要翻译：方法和设备，包括计算机程序产品，授权进行货币转移的实施和使用技术。创建一个提案。提案指定一个或多个命名的第三方，一个或多个指定的动作，以及要完成一个或多个指定动作的时间框架。该提案分发给一个或多个命名的第三方。一个或多个命名的第三方中的每一个在提案中指定的时间范围内完成指定的操作。响应于一个或多个指定的第三方完成的一个或多个指定的动作，给出处理货币转移的授权。

10. 发明申请

US20070265264A1 Thia-tetraazaacenaphthylene kinase inhibitors 有权
标题翻译： Thia-tetraaza苊烯激酶抑制剂
公开(公告)号：US20070265264A1
公开(公告)日：2007-11-15
申请号：US11401339
申请日：2006-04-10
申请人： Kathleen Battista , Gilles Bignan , Peter Connolly , Stuart Hayden , Sigmond Johnson , Ronghui Lin , Niranjan Pandey , Mark Powell
发明人： Kathleen Battista , Gilles Bignan , Peter Connolly , Stuart Hayden , Sigmond Johnson , Ronghui Lin , Niranjan Pandey , Mark Powell
IPC分类号： A61K31/505 , A61K31/5377 , A61P19/02 , A61P19/08 , A61P25/00 , A61P25/16 , A61P25/28 , A61P31/12 , A61P35/00 , A61P9/10 , C07D239/00 , C07D413/14
CPC分类号： C07D495/16
摘要： The present invention is directed to novel thia-tetraazaacenaphthylene compounds of Formula (I): and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of ATP-protein kinase interactions.
摘要翻译：本发明涉及式（I）的新型硫代四氮杂苊烯化合物及其药学上可接受的形式，以及它们作为ATP-蛋白激酶相互作用抑制剂的合成和用途。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式